(Total Views: 475)
Posted On: 08/31/2021 7:59:22 AM
Post# of 36566
Hopefully, we find out very soon where things are at with the IND, the IPO ( long overdue), and all the other Generex/NuGenerex initiatives.
Since the FDA doesn’t send an approval letter for an IND ( 30 day window) and we have not heard about the human trials starting, so many questions are in the air.
Was the IND submitted? If it was submitted, when did that happen?
If it was submitted, has there been any communication ( Clinical Hold) from the FDA before trials can start?
Is the IND holding up the IPO, or are these mutually exclusive events?
Four months since the last CC…why does all of this have to be such a secret?
Since the FDA doesn’t send an approval letter for an IND ( 30 day window) and we have not heard about the human trials starting, so many questions are in the air.
Was the IND submitted? If it was submitted, when did that happen?
If it was submitted, has there been any communication ( Clinical Hold) from the FDA before trials can start?
Is the IND holding up the IPO, or are these mutually exclusive events?
Four months since the last CC…why does all of this have to be such a secret?
(6)
(0)
